FDA Approved: MELOXICAM — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MELOXICAM from Cipla USA Inc., authorizing changes to an existing meloxicam product under an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

SUPPL AP for MELOXICAM (MELOXICAM)